And Kinner, on your questions on the impact of moving to the 6% target on loss-absorbing capital, obviously, as we've said, we're beginning a program of issuance. You have the cost of issuance on deal one. We'd expect as we continue to improve our capital ratios and buffer that we have that our issuance costs would decrease. But as I noted in my remarks, that certainly will be a drag on our performance. Next, in terms of your question about what happens in the event of a Moody's downgrade, the loss of P1 rating, first, I would say unequivocally that I think the numbers that we've reported and the position of UBS is completely inconsistent with a firm that would be downgraded from P1, and we've obviously made our thoughts known in our discussions with Moody's. We've obviously done, nevertheless, we've done the appropriate contingency plan that you would expect us to do. And based on that, we feel comfortable that we have the plans in place to address that. We're still carrying substantial liquidity positions of 23% of the balance sheet. We've also, in terms of our commercial paper program, we've actually been very focused on ensuring that we're getting both the pricing and the tenor that we expect, and we've been refusing just to roll overnight money for the purpose of keeping the program larger. Then finally on IB RWAs, you asked for a little bit more detail, I'd refer you to Slide 24 and I'll try to walk you through, on the credit risk side, the reductions of 9 billion were, really, all risk-reduction related. On the market risk side, the other piece of it, we had a number of ins and outs, some risk reduction as well as some model changes in the aggregate in the IB core. It's about 60% of risk adjustments that led to the reduction and about 40% of model adjustments. And then finally, you didn't ask this, but I'll try to give a clarity on legacy -- sorry, on the Basel III uplift piece. So I'll explain the Basel 2.5 changes first. On the Basel III uplift, our net model adjustments on the uplift portion actually added 2 billion in RWAs for the quarter, and then we had ins and outs that roughly offset each other where the legacy sold off positions that cost 3 billion in reductions in RWAs during the quarter. So the way to think 21 billion in Basel III is 21 billion in Basel 2.5, neutral on the Basel III uplift.